Trying to Reach Earlier: Noninvasive Imaging Findings Suggestive of Pulmonary Vascular Bed Changes in RING Finger Protein 213 p.R4810K Carriers.
作者信息
Falconi Mariano
机构信息
Hospital Italiano de Buenos Aires Buenos Aires Argentina.
出版信息
J Am Heart Assoc. 2025 Feb 4;14(3):e039523. doi: 10.1161/JAHA.124.039523. Epub 2025 Jan 27.
Abstract
摘要
相似文献
1
Trying to Reach Earlier: Noninvasive Imaging Findings Suggestive of Pulmonary Vascular Bed Changes in RING Finger Protein 213 p.R4810K Carriers.尽早发现：非侵入性成像结果提示无名指蛋白213 p.R4810K携带者的肺血管床改变
J Am Heart Assoc. 2025 Feb 4;14(3):e039523. doi: 10.1161/JAHA.124.039523. Epub 2025 Jan 27.
2
Relationship Between p.R4810K and Echocardiographic Findings in Patients with Cerebrovascular Diseases: A Multicenter Prospective Cohort Study.脑血管疾病患者中p.R4810K与超声心动图检查结果的关系：一项多中心前瞻性队列研究
J Am Heart Assoc. 2025 Feb 4;14(3):e036333. doi: 10.1161/JAHA.124.036333. Epub 2025 Jan 27.
3
RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.RNF213基因p.R4810K多态性与烟雾病、颅内主要动脉狭窄/闭塞及类烟雾病的风险：一项荟萃分析
J Stroke Cerebrovasc Dis. 2018 Aug;27(8):2259-2270. doi: 10.1016/j.jstrokecerebrovasdis.2018.04.013. Epub 2018 May 8.
4
Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.东亚和东南亚人群中RNF213基因的烟雾病易感性多态性p.R4810K的分布。
Neurol Med Chir (Tokyo). 2012;52(5):299-303. doi: 10.2176/nmc.52.299.
5
Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.烟雾病易感变异体RNF213 p.R4810K在日本人群中的频率及携带者的健康特征。
Environ Health Prev Med. 2016 Sep;21(5):387-390. doi: 10.1007/s12199-016-0549-8. Epub 2016 Jun 30.
6
High-resolution MRI vessel wall enhancement in moyamoya disease: risk factors and clinical outcomes.高分辨率 MRI 血管壁增强在烟雾病中的应用：危险因素和临床转归。
Eur Radiol. 2024 Aug;34(8):5179-5189. doi: 10.1007/s00330-023-10535-0. Epub 2024 Jan 4.
7
p.R4810K (c.14429G > A) Variant Determines Anatomical Variations of the Circle of Willis in Cerebrovascular Disease.p.R4810K（c.14429G＞A）变异决定了脑血管疾病中 Willis 环的解剖变异。
Front Aging Neurosci. 2021 Jul 15;13:681743. doi: 10.3389/fnagi.2021.681743. eCollection 2021.
8
The association between the ring finger protein 213 gene R4810K variant and intracranial major artery stenosis/occlusion in the Han Chinese population and high-resolution magnetic resonance imaging findings.汉族人群中无名指蛋白213基因R4810K变异与颅内主要动脉狭窄/闭塞的关联及高分辨率磁共振成像结果
Brain Circ. 2018 Jan-Mar;4(1):33-39. doi: 10.4103/bc.bc_9_17. Epub 2018 Apr 18.
9
RNF213 p.R4810K Variant Carriers with Intracranial Arterial Stenosis Have a Low Atherosclerotic Burden.携带 RNF213 p.R4810K 变异的颅内动脉狭窄患者的动脉粥样硬化负担较低。
J Atheroscler Thromb. 2022 Nov 1;29(11):1655-1662. doi: 10.5551/jat.63379. Epub 2021 Dec 25.
10
Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.RNF213 罕见变异与烟雾病/非烟雾病颅内动脉狭窄/闭塞性疾病风险：Meta 分析和系统评价。
Environ Health Prev Med. 2017 Nov 2;22(1):75. doi: 10.1186/s12199-017-0680-1.
本文引用的文献
1
Relationship Between p.R4810K and Echocardiographic Findings in Patients with Cerebrovascular Diseases: A Multicenter Prospective Cohort Study.脑血管疾病患者中p.R4810K与超声心动图检查结果的关系：一项多中心前瞻性队列研究
J Am Heart Assoc. 2025 Feb 4;14(3):e036333. doi: 10.1161/JAHA.124.036333. Epub 2025 Jan 27.
2
Prevalence and Clinical Characteristics of Heterozygous Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension.杂合变异携带者诊断为慢性血栓栓塞性肺动脉高压的患病率和临床特征。
J Am Heart Assoc. 2024 Aug 6;13(15):e035009. doi: 10.1161/JAHA.124.035009. Epub 2024 Jul 26.
3
Pulmonary Artery Dilatation Due to Pressure or Volume Overload in Congenital Heart Disease.先天性心脏病中因压力或容量负荷过重导致的肺动脉扩张
J Clin Med. 2024 Mar 9;13(6):1567. doi: 10.3390/jcm13061567.
4
Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association.成人烟雾病和综合征：现状和未来方向：美国心脏协会/美国中风协会的科学声明。
Stroke. 2023 Oct;54(10):e465-e479. doi: 10.1161/STR.0000000000000443. Epub 2023 Aug 23.
5
Moyamoya disease: diagnosis and interventions.烟雾病：诊断与干预。
Lancet Neurol. 2022 Aug;21(8):747-758. doi: 10.1016/S1474-4422(22)00165-X. Epub 2022 May 20.
6
The Genetic Basis of Moyamoya Disease.Moyamoya 病的遗传学基础。
Transl Stroke Res. 2022 Feb;13(1):25-45. doi: 10.1007/s12975-021-00940-2. Epub 2021 Sep 16.
7
Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.携带 RNF213 变异（p.Arg4810Lys）的肺动脉高压患者预后不良。
J Heart Lung Transplant. 2020 Feb;39(2):103-112. doi: 10.1016/j.healun.2019.08.022. Epub 2019 Sep 2.
8
Assessment of pulmonary artery pressure by echocardiography-A comprehensive review.超声心动图评估肺动脉压——综述
Int J Cardiol Heart Vasc. 2016 Jul 4;12:45-51. doi: 10.1016/j.ijcha.2016.05.011. eCollection 2016 Sep.
9
Moyamoya disease: a review of the literature.烟雾病：文献综述
Appl Neuropsychol Adult. 2014;21(1):21-7. doi: 10.1080/09084282.2012.721147. Epub 2013 Jun 14.
10
Use of echocardiographic pulmonary acceleration time and estimated vascular resistance for the evaluation of possible pulmonary hypertension.利用超声心动图测量的肺动脉加速时间和估计的血管阻力评估可能存在的肺动脉高压。
Cardiovasc Ultrasound. 2013 Feb 27;11:7. doi: 10.1186/1476-7120-11-7.
Zotero 插件